(Drug Target Review) – A ground-breaking blood test to assess patients with suspected mild traumatic brain injuries (TBIs) or concussions has been used by Orlando Health Orlando Regional Medical Center (ORMC). The institution will be the first hospital system in the world to roll it out.
Named i-STAT TBI, the novel blood test was developed by Abbott in collaboration with the Department of Defense, following the research conducted by Dr Linda Papa, Director of Clinical Research at Orlando Health, and her colleagues.
There is a prevalent requirement for a blood test to diagnose and treat injuries of the brain, as TBIs from accidents or sports is a leading cause of death and disability in the United States. CONTINUE